Home / Going-concern warnings / NEUROONE MEDICAL TECHNOLOGIES Corp
Filed 2026-02-17 路 Form 10-Q 路 Accession 0001213900-26-016860 nano
Price before filing: $4.88 (2026-02-13 close, split/dividend-adjusted)
Market cap at flag: $34.3M (2026-02-17) 路 Latest: $8.3M (2026-10-16)
| Window | NMTC | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -10.9% | -3.2% | -7.6% | 2026-03-19 |
| 90 days | -7.2% | +8.6% | -15.8% | 2026-05-18 |
| 180 days | -61.5% | +13.9% | -75.4% | 2026-08-17 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: no open-market insider sales or purchases reported.
30 days after: 1 insider sold $12K (4 sales); 1 insider bought $670K (1 purchase)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-02-17: red flag filed | |||||||
| 2026-03-01 | Wambeke David J. Chief Business Officer | Purchase | 1,000,000 | $0.67 | $670K | no | Form 4 |
| 2026-03-10 | Christianson Mark Business Development Director | Sale | 11,611 | $0.80 | $9K | no | Form 4 |
| 2026-03-11 | Christianson Mark Business Development Director | Sale | 2,109 | $0.80 | $2K | no | Form 4 |
| 2026-03-12 | Christianson Mark Business Development Director | Sale | 817 | $0.80 | $654 | no | Form 4 |
| 2026-03-13 | Christianson Mark Business Development Director | Sale | 100 | $0.80 | $80 | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-11-19 to 2026-03-19. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"These factors raise substantial doubt about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-12-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.